Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
47.14
-1.56 (-3.20%)
At close: Apr 28, 2026, 4:00 PM EDT
47.11
-0.03 (-0.06%)
After-hours: Apr 28, 2026, 6:08 PM EDT
Moderna Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Moderna stock have an average target of 34.27, with a low estimate of 18 and a high estimate of 69. The average target predicts a decrease of -27.30% from the current stock price of 47.14.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Moderna stock from 12 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 8 | 9 | 9 | 9 | 9 | 9 |
| Sell | 3 | 3 | 3 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 13 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $25 → $48 | Hold | Maintains | $25 → $48 | +1.82% | Apr 2, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $63 → $69 | Buy | Maintains | $63 → $69 | +46.37% | Feb 23, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $36 → $41 | Hold | Maintains | $36 → $41 | -13.03% | Feb 17, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $25 → $30 | Hold | Maintains | $25 → $30 | -36.36% | Feb 17, 2026 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $28 → $35 | Hold | Maintains | $28 → $35 | -25.75% | Feb 17, 2026 |
Financial Forecast
Revenue This Year
2.13B
from 1.94B
Increased by 9.36%
Revenue Next Year
2.45B
from 2.13B
Increased by 15.43%
EPS This Year
-7.13
from -7.25
EPS Next Year
-5.04
from -7.13
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 2.4B | 3.6B | ||||||
| Avg | 2.1B | 2.5B | ||||||
| Low | 1.8B | 1.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 21.0% | 68.9% | ||||||
| Avg | 9.4% | 15.4% | ||||||
| Low | -9.1% | -16.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -5.29 | -3.54 | ||||||
| Avg | -7.13 | -5.04 | ||||||
| Low | -8.87 | -6.29 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.